Kamel Ghribi

Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

Distinguished entrepreneur and visionary, Kamel Ghribi, has significantly transformed healthcare delivery across the Middle East through his pioneering smart clinics. As the Chairman of GKSD Healthcare, Ghribi has seamlessly integrated innovative healthcare solutions with sustainable practices, setting a new benchmark in the region. The Success of Smart Clinics in the Middle East Under Ghribi’s leadership, GKSD Healthcare has expanded its footprint across the Middle East … Continue reading Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

JOHNSON & JOHNSON

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders CAPLYTA® adds to Johnson & Johnson’s robust lineup of … Continue reading Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

American Cancer Society

American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access

Oct 28, 2024 – ACS Impact Venture Fund (AIVF)’s active portfolio of 16 companies is transforming the fight against cancer through impact investing BOSTON, Oct. 28, 2024 – BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress in the fight to end cancer as we know it. Since inception through EOY 2023, BrightEdge has invested … Continue reading American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access

Gruppo San Donato

Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

The new company envisages the development of a network that will include a hundred structures by 2030 and will be chaired by Vito Cozzoli and led by CEO Bonifacio Moroni Press Release – The closing of the strategic agreement between San Donato Group, GKSD e Generali Italy: born Smart Clinic SpA, The company joint venture which aims to create, by 2030, a network of approximately 100 healthcare facilities across the entire Italian territory. … Continue reading Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

Iridex

Iridex Appoints Patrick Mercer as Chief Executive Officer

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the appointment of Patrick Mercer as the Company’s Chief Executive Officer and President effective October 1, 2024. Previously Mr. Mercer served as the Company’s Chief Operating Officer and President. David Bruce, the Company’s prior Chief Executive … Continue reading Iridex Appoints Patrick Mercer as Chief Executive Officer